Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00345631 · ClinicalTrials.gov registry record · Phase 3
Safety and Effectiveness Study of the Ensure Medical Vascular Closure Device
A Phase 3 study, sponsored by Cordis US.
- Completed
- Registry status
- Phase 3
- Development phase
- 488
- Enrollment target
NCT00345631 is a Phase 3 study that has completed, run by Cordis US. The registered enrollment target is 488 participants.
The verdict
NCT00345631, a Phase 3 study, has completed, sponsored by Cordis US.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 488 participants
- Enrollment target
Study Summary
The purpose of this study is to determine whether the Ensure Medical Vascular Closure Device is more effective than standard manual compression at sealing the puncture made in the femoral artery following a cardiac or peripheral diagnostic or interventional procedure while maintaining the same level of safety.
Interventions
- OTHER Manual Compression
- DEVICE Vascular Closure Device
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 488 participants |
| Start Date | 2007-02 |
| Est. Completion | 2007-09 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00345631
The ClinicalTrials.gov registry entry for NCT00345631 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 488 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Cordis US, which has 19 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Manual Compression is the first listed.
NCT00345631 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00345631 about?
NCT00345631 is a clinical study titled "Safety and Effectiveness Study of the Ensure Medical Vascular Closure Device". The purpose of this study is to determine whether the Ensure Medical Vascular Closure Device is more effective than standard manual compression at sealing the puncture made in the femoral artery following a cardiac or peripheral diagnostic or interventional procedure while maintaining the same level...
What is the current status of trial NCT00345631?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 488 participants. The study started on 2007-02. Estimated completion is 2007-09.
What interventions are being tested in trial NCT00345631?
The interventions under investigation include: Manual Compression (OTHER), Vascular Closure Device (DEVICE).
Who is sponsoring clinical trial NCT00345631?
This trial is sponsored by Cordis US, which has 19 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.